Elevated activation of YAP/TAZ is implicated in tumor initiation, metastasis, and drug resistance through mechanisms including inhibition of apoptosis and reprogramming of metabolic pathways in tumor cells (Liu et al., 2021; Fu et al., 2022). The gene discussed is YAP1; the disease is neoplasm.